SCHEMBL2155244

SCHEMBL2155244

Cc1ccc2c(c1)C(=O)C(CCC(=O)O)(CCC(=O)O)CO2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
HTT P42858 3/20 0.40
TSHR P16473 2/20 0.40
CYP19A1 P11511 1/20 0.39
AKR1B1 P15121 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA4 P22748 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
KDM4E B2RXH2 5/20 0.35
ATM Q13315 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
RAD52 P43351 1/20 0.35
POLB P06746 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MMP12 P39900 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2156098 0.90 CYP19A1 (0.39) MEN1KMT2ACYP1A2CYP2C9HTT
SCHEMBL2156976 0.81 APEX1 (0.44) MEN1KMT2ACYP2C9HTTTSHR
SCHEMBL2156917 0.80 PLA2G10 (0.39) AKR1B1
SCHEMBL2155247 0.79 PRKCA (0.40) MEN1KMT2ACYP1A2CYP2C9HTT
SCHEMBL2155906 0.79 SIRT2 (0.34) MEN1KMT2ATSHRHPGD
SCHEMBL2155276 0.77 MAPT (0.40) MEN1KMT2AHTTTSHRCA2
SCHEMBL2155852 0.76 CYP19A1 (0.43) MEN1KMT2ACYP1A2HTTCYP19A1
SCHEMBL2155655 0.74 APEX1 (0.37) MEN1KMT2ACYP1A2CYP2C9CA1
SCHEMBL4620985 0.71 CYP19A1 (0.42) MEN1KMT2ACYP1A2CYP2C9HTT
SCHEMBL2155246 0.71 TSHR (0.39) TSHRKDM4EL3MBTL1HSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080161352-A1 Substituted Benzo-Condensed Cycloheptanone Derivatives and the Use Thereof for Medicament Production GRUENENTHAL GMBH (DE) 2008-07-03 US claimed
US-7973072-B2 Pain, eating disorders, neurodegenerative disorders, memory impairment; attention deficit syndrome, opioid tolerance, drug addiction; (4-oxothiochroman-3,3-diyl)bis(methylene)bis(3-(trifluoromethyl)benzoate for example GRUENENTHAL GMBH (DE) 2011-07-05 US disclosed
US-20080161352-A1 Substituted Benzo-Condensed Cycloheptanone Derivatives and the Use Thereof for Medicament Production GRUENENTHAL GMBH (DE) 2008-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161352-A1 Substituted Benzo-Condensed Cycloheptanone Derivatives and the Use Thereof for Medicament Production BCKDK, SYMPK, DHPS MEN1 2879/4885KMT2A 3098/4885CYP1A2 136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.